| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |